Lepu in Action: Lepu Medical Helps 140+ Countries to Fight against COVID-19

zhangcuicui / 2021-03-24

In February 2021, the SARS-CoV-2 Antigen Rapid Test Kit developed by Beijing Lepu Medical Technology CO,.LTD. the major subsidiary of Lepu Medical, was selected on the recommendation list provided by European Commissioner for Health and Food Safety, which indicates that Lepu SARS-CoV-2 Antigen Rapid Test Kit was officially recommended by the European Union.

 Figure 1. Lepu Beijing Headquarter


Early this year, Lepu Medical Technology CO,.LTD. was recognized as a ''Leading Entity" by the Ministry of Industry and Information Technology of China, for actively fighting against COVID-19. The company’s automatic PCR analysis system, automatic nucleic acid extractor, disposable sampling tubes and other related products are widely used in hospitals, medical centers, and testing laboratories in China.

Figure 2. Award of “Leading Entity” issued by MIIT


As the pandemic deteriorates globally, Lepu has been focusing on R&D and manufacture, aiding the world with high-quality medical products. Its test kits, such as SARS-CoV-2 Antibody Test, 2019-nCoV Antigen Rapid Test Kit, and SARS-CoV2 Nucleic Acid Test Kit have received CE marks and are popular on EU market.

Figure 3 . 1 million antigen tests being loaded on the cargo airplane to Europe

Figure 4. Lepu test kits


 In addition, with both CE and FDA approvals, Lepu’s three infrared forehead thermometers (LFR30B, LFR50, LFR60) were delivered to Europe and the United States.

Figure 5. Lepu infrared forehead thermometers


Meanwhile, Lepu has been actively contributing to global partnership. In January 2021, Lepu provided over 20 million antigen test kits to all the school students in Austria. This has helped the Austrian Federal Ministry of Education, Science and Research achieve its goal on national-wide COVID-19 tests in all schools.

Figure 6. Austrian students using Lepu antigen tests


According to the World Health Organization, more than 110 million confirmed cases of COVID-19 have been reported globally. It is predicted that the pandemic will last for a long time. Facing this challenge, Lepu aims to provide professional and reliable products to the world. So far, Lepu’s anti-COVID-19 products have gone to over 140 countries, and Lepu will constantly deliver high-quality and innovative products to keep addressing the global medical needs.

Figure 7. Lepu Beijing Headquarter Campus 


Source: Beijing Lepu Medical Technology CO,.LTD.